ISA Group promotes pioneering research projects in Colombia, led by CES University to address the COVID-19 pandemic

Share

The agreement signed between the company and the university includes two scopes: First, developing a project to implement Convalescent Plasma, which is the first clinical trial of its kind in Colombia as an alternative treatment while a vaccine is developed.

OTHER RELEVANT INFORMATION

CONTACT US

SHAREHOLDER CHAT

Do you have questions? Do you want to make the most of your investment?

Real-time chat. One of our advisors will guide you to clarify doubts about your investment